Single vector system for efficient N-myristoylation of recombinant proteins in E. coli

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Glück, Julian M ^a,b   Hoffmann, Silke ^a   Koenig, Bernd W ^a,b   Willbold, Dieter ^a,b  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEF PROTEIN; PROTEIN N MYRISTOYLTRANSFERASE; ACYLTRANSFERASE; GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE; MYRISTIC ACID DERIVATIVE; RECOMBINANT PROTEIN;

ARTICLE; AT RICH SEQUENCE; CONTROLLED STUDY; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE EXPRESSION SYSTEM; HETEROLOGOUS EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR CLONING; MYRISTYLATION; NONHUMAN; PLASMID; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PURIFICATION; RECOMBINANT DNA TECHNOLOGY; GENE VECTOR; GENETICS; METABOLISM; METHODOLOGY; TECHNIQUE;

EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS 1; PROKARYOTA;

ACYLTRANSFERASES; CLONING, MOLECULAR; ESCHERICHIA COLI; GENETIC VECTORS; METHODS; MYRISTIC ACIDS; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS;

EID: 77956326862     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010081     Document Type: Article

References (52)

1. Resh MD (1999) Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim Biophys Acta 1451: 1-16.
2. Farazi TA, Waksman G, Gordon JI (2001) The biology and enzymology of protein N-myristoylation. J Biol Chem 276: 39501-39504.
3. Carr SA, Biemann K, Shoji S, Parmelee DC, Titani K (1982) n-Tetradecanoyl is the NH2-terminal blocking group of the catalytic subunit of cyclic AMPdependent protein kinase from bovine cardiac muscle. Proc Natl Acad Sci USA 79: 6128-6131.
4. Boutin JA (1997) Myristoylation. Cell Signal 9: 15-35.
5. Weaver TA, Panganiban AT (1990) N myristoylation of the spleen necrosis virus matrix protein is required for correct association of the Gag polyprotein with intracellular membranes and for particle formation. J Virol 64: 3995-4001.
6. Tanaka T, Ames JB, Harvey TS, Stryer L, Ikura M (1995) Sequestration of the membrane-targeting myristoyl group of recoverin in the calcium-free state. Nature 376: 444-447.
7. Yonemoto W, McGlone ML, Taylor SS (1993) N-myristylation of the catalytic subunit of cAMP-dependent protein kinase conveys structural stability. J Biol Chem 268: 2348-2352.
8. Zheng J, Knighton DR, Xuong NH, Taylor SS, Sowadski JM, et al. (1993) Crystal structures of the myristylated catalytic subunit of cAMP-dependent protein kinase reveal open and closed conformations. Protein Sci 2: 1559-1573.
9. Burnette B, Kahn R, Glover CJ, Felsted RL (1992) Bacterial expression, purification, and in vitro N-myristoylation of HIV-1 p17gag. Protein Expr Purif 3: 395-402.
10. Ma HH, Yang L, Yang XY, Xu ZP, Li BL (2003) Bacterial expression, purification, and in vitro N-myristoylation of fusion hepatitis B virus preS1 with the native-type N-terminus. Protein Expr Purif 27: 49-54.
11. Ames JB, Tanaka T, Stryer L, Ikura M (1994) Secondary structure of myristoylated recoverin determined by three-dimensional heteronuclear NMR: implications for the calcium-myristoyl switch. Biochemistry 33: 10743-10753.
12. Breuer S, Gerlach H, Kolaric B, Urbanke C, Opitz N, et al. (2006) Biochemical indication for myristoylation-dependent conformational changes in HIV-1 Nef. Biochemistry 45: 2339-2349.
13. Duronio RJ, Jackson-Machelski E, Heuckeroth RO, Olins PO, Devine CS, et al. (1990) Protein N-myristoylation in Escherichia coli: reconstitution of aeukaryotic protein modification in bacteria. Proc Natl Acad Sci USA 87: 1506-1510.
14. Ladant D (1995) Calcium and membrane binding properties of bovine neurocalcin delta expressed in Escherichia coli. J Biol Chem 270: 3179-3185.
15. Lim S, Peshenko I, Dizhoor A, Ames JB (2009) Effects of Ca2+, Mg2+, and myristoylation on guanylyl cyclase activating protein 1 structure and stability. Biochemistry 48: 850-862.
16. Liu Y, Kahn RA, Prestegard JH (2009) Structure and membrane interaction of myristoylated ARF1. Structure 17: 79-87.
17. Ray S, Zozulya S, Niemi GA, Flaherty KM, Brolley D, et al. (1992) Cloning, expression, and crystallization of recoverin, a calcium sensor in vision. Proc Natl Acad Sci USA 89: 5705-5709.
18. Arien KK, Verhasselt B (2008) HIV Nef: role in pathogenesis and viral fitness. Curr HIV Res 6: 200-208.
19. Foster JL, Garcia JV (2008) HIV-1 Nef: at the crossroads. Retrovirology 5: 84.
20. Kirchhoff F (2009) Is the high virulence of HIV-1 an unfortunate coincidence of primate lentiviral evolution? Nat Rev Microbiol 7: 467-476.
21. Willbold D (2005) Interaction of HIV-1 Nef with Human CD4 and Lck. In: Fisher W, ed. Viral Membrane Proteins: Structure, Function, and Drug Design. New York: Kluwer Academic Publishers. pp 269-286.
22. Harrer E, Bauerle M, Ferstl B, Chaplin P, Petzold B, et al. (2005) Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption. Antivir Ther 10: 285-300.
23. Baur AS, Sass G, Laffert B, Willbold D, Cheng-Mayer C, et al. (1997) The Nterminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity 6: 283-291.
24. Witte V, Laffert B, Rosorius O, Lischka P, Blume K, et al. (2004) HIV-1 Nef mimics an integrin receptor signal that recruits the polycomb group protein Eed to the plasma membrane. Mol Cell 13: 179-190.
25. Renkema GH, Saksela K (2000) Interactions of HIV-1 NEF with cellular signal transducing proteins. Front Biosci 5: D268-283.
26. Roeth JF, Collins KL (2006) Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways. Microbiol Mol Biol Rev 70: 548-563.
27. Fackler OT, Baur AS (2002) Live and let die: Nef functions beyond HIV replication. Immunity 16: 493-497.
28. Benson RE, Sanfridson A, Ottinger JS, Doyle C, Cullen BR (1993) Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J Exp Med 177: 1561-1566.
29. Michel N, Allespach I, Venzke S, Fackler OT, Keppler OT (2005) The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4. Curr Biol 15: 714-723.
30. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM (1996) Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 2: 338-342.
31. Stumptner-Cuvelette P, Morchoisne S, Dugast M, Le Gall S, Raposo G, et al. (2001) HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc Natl Acad Sci USA 98: 12144-12149.
32. Schindler M, Munch J, Kutsch O, Li H, Santiago ML, et al. (2006) Nefmediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125: 1055-1067.
33. Fackler OT, Krausslich HG (2006) Interactions of human retroviruses with the host cell cytoskeleton. Curr Opin Microbiol 9: 409-415.
34. Bentham M, Mazaleyrat S, Harris M (2006) Role of myristoylation and Nterminal basic residues in membrane association of the human immunodeficiency virus type 1 Nef protein. J Gen Virol 87: 563-571.
35. Giese SI, Woerz I, Homann S, Tibroni N, Geyer M, et al. (2006) Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef. Virology 355: 175-191.
36. Shuman S (1990) Catalytic activity of vaccinia mRNA capping enzyme subunits coexpressed in Escherichia coli. J Biol Chem 265: 11960-11966.
37. Kim KJ, Kim HE, Lee KH, Han W, Yi MJ, et al. (2004) Two-promoter vector is highly efficient for overproduction of protein complexes. Protein Sci 13: 1698-1703.
38. Arold ST, Baur AS (2001) Dynamic Nef and Nef dynamics: how structure could explain the complex activities of this small HIV protein. Trends Biochem Sci 26: 356-363.
39. Hoffmann S, Jonas E, Konig S, Preusser-Kunze A, Willbold D (2007) Nef protein of human immunodeficiency virus type 1 binds its own myristoylated Nterminus. Biol Chem 388: 181-183.
40. Ames JB, Ishima R, Tanaka T, Gordon JI, Stryer L, et al. (1997) Molecular mechanics of calcium-myristoyl switches. Nature 389: 198-202.
41. Hermida-Matsumoto L, Resh MD (1999) Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA. J Virol 73: 1902-1908.
42. Gerlach H, Laumann V, Martens S, Becker CF, Goody RS, et al. (2010) HIV-1 Nef membrane association depends on charge, curvature, composition and sequence. Nat Chem Biol 6: 46-53.
43. Glover CJ, Hartman KD, Felsted RL (1997) Human N-myristoyltransferase amino-terminal domain involved in targeting the enzyme to the ribosomal subcellular fraction. J Biol Chem 272: 28680-28689.
44. Ahn T, Yun CH (2004) High-level expression of human cytochrome P450 3A4 by co-expression with human molecular chaperone HDJ-1 (Hsp40). Arch Pharm Res 27: 319-323.
45. Gillam EM, Wunsch RM, Ueng YF, Shimada T, Reilly PE, et al. (1997) Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase. Arch Biochem Biophys 346: 81-90.
46. Briese L, Preusser A, Willbold D (2005) Mapping the binding site of full length HIV-1 Nef on human Lck SH3 by NMR spectroscopy. J Biomed Sci 12: 451-456.
47. Glück JM, Wittlich M, Feuerstein S, Hoffmann S, Willbold D, et al. (2009) Integral membrane proteins in nanodiscs can be studied by solution NMR spectroscopy. J Am Chem Soc 131: 12060-12061.
48. Preusser A, Briese L, Baur AS, Willbold D (2001) Direct in vitro binding of fulllength human immunodeficiency virus type 1 Nef protein to CD4 cytoplasmic domain. J Virol 75: 3960-3964.
49. Preusser A, Briese L, Willbold D (2002) Presence of a helix in human CD4 cytoplasmic domain promotes binding to HIV-1 Nef protein. Biochem Biophys Res Commun 292: 734-740.
50. Stangler T, Tran T, Hoffmann S, Schmidt H, Jonas E, et al. (2007) Competitive displacement of full-length HIV-1 Nef from the Hck SH3 domain by a highaffinity artificial peptide. Biol Chem 388: 611-615.
51. Wittlich M, Koenig BW, Hoffmann S, Willbold D (2007) Structural characterization of the transmembrane and cytoplasmic domains of human CD4. Biochim Biophys Acta 1768: 2949-2960.
52. Duronio RJ, Reed SI, Gordon JI (1992) Mutations of human myristoyl-CoA:protein N-myristoyltransferase cause temperature-sensitive myristic acid auxotrophy in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 89: 4129-4133.